Histidine Ammonia-Lyase (HAL) Peptid
HAL
Reaktivität: Säugetier
Wirt: Synthetic
BP, IHC, WB
-
- Target Alle HAL Produkte
- HAL (Histidine Ammonia-Lyase (HAL))
- Protein-Typ
- Synthetic
- Spezies
- Säugetier
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
- Sequenz
- EAAHRLLLEQ KVWEVAAPYI EKYRMEHIPE SRPLSPTAFS LQFLHKKSTK
- Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of HAL antibody,
Alternative Names: HAL control peptide, HAL antibody Blocking Peptide, Anti-HAL Blocking Peptide, Histidine Ammonia-Lyase Blocking Peptide, HIS Blocking Peptide, HSTD Blocking Peptide
-
-
- Applikationshinweise
- Optimal conditions should be determined by the investigator
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handhabung
- Avoid repeated freeze/thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20 °C long term.
-
- Target
- HAL (Histidine Ammonia-Lyase (HAL))
- Hintergrund
- HAL is a cytosolic enzyme catalyzing the first reaction in histidine catabolism, the nonoxidative deamination of L-histidine to trans-urocanic acid. HAL defects cause histidinemia which is characterized by increased histidine and histamine and decreased urocanic acid in body fluidsHistidine ammonia-lyase is a cytosolic enzyme catalyzing the first reaction in histidine catabolism, the nonoxidative deamination of L-histidine to trans-urocanic acid. Histidine ammonia-lyase defects cause histidinemia which is characterized by increased histidine and histamine and decreased urocanic acid in body fluids.
- Molekulargewicht
- 72 kDa
-
Sie sind hier:
